Antibacterial Effects of Statins
Author Information
Author(s): Bergman Peter, Linde Charlotte, Pütsep Katrin, Pohanka Anton, Normark Staffan, Henriques-Normark Birgitta, Andersson Jan, Björkhem-Bergman Linda
Primary Institution: Karolinska Institutet
Hypothesis
The study aimed to elucidate possible antibacterial effects of statins against primary pathogens of the respiratory tract.
Conclusion
Simvastatin at high concentrations can kill certain bacteria, but these concentrations are much higher than those found in human blood during therapy.
Supporting Evidence
- Simvastatin showed a MIC-value of 15 µg/mL against S. pneumoniae.
- Fluvastatin and Pravastatin showed no antibacterial effect up to 100 µg/mL.
- Single doses of statins did not improve antibacterial effects in whole blood.
- Statins did not affect the growth of H. influenzae.
Takeaway
The study looked at whether statins, which are usually used for heart problems, can also kill bacteria that cause lung infections. It found that while statins can kill some bacteria in the lab, they don't work the same way in real people.
Methodology
The study used traditional antibacterial assays to determine MIC-values and monitored bacterial growth using a BioScreen instrument.
Potential Biases
The study acknowledges potential publication bias in previous observational studies.
Limitations
The study only examined a single dose of statins and cannot rule out long-term effects.
Participant Demographics
Five healthy volunteers were recruited for the in vivo experiments.
Statistical Information
P-Value
p=0.03
Confidence Interval
95% CI 0.42–0.66
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website